Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Kates

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Urologic Oncology|February 23, 2016
Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomyMeera R Chappidi, Max Kates, Hiten D Patel, et al.
Plos One|December 17, 2020
Development and validation of a NanoString BASE47 bladder cancer gene classifierJordan Kardos, Tracy L Rose, Ujjawal Manocha, et al.
The Journal of Urology|January 9, 2018
Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial CarcinomaRoss S Liao, Mohit Gupta, Zeyad R Schwen, et al.
European Urology|November 5, 2021
A Molecular Inquiry into the Role of Antibody-Drug Conjugates in Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder CancerWoonyoung Choi, Kara Lombardo, Sunil Patel, et al.
NMR in Biomedicine|December 21, 2022
Exploring the potential of the novel imidazole-4,5-dicarboxyamide chemical exchange saturation transfer scaffold for pH and perfusion imagingShaowei Bo, Julia Stabinska, Yunkou Wu, et al.
The Journal of Urology|February 9, 2026
Results from the ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) Randomized Controlled TrialMichael E Rezaee, Michelle I Higgins, Zhuo Tony Su, et al.
The Journal of Urology|July 5, 2014
Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failureJames M McKiernan, Dara D Holder, Rashed A Ghandour, et al.
Urologic Oncology|July 13, 2015
Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification toolsDanny Lascano, Jamie S Pak, Max Kates, et al.
European Urology|July 20, 2016
Ex Vivo Model of Human Penile Transplantation and Rejection: Implications for Erectile Tissue PhysiologyNikolai A Sopko, Hotaka Matsui, Denver M Lough, et al.
Urology|November 20, 2013
Survival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical managementHiten D Patel, Max Kates, Phillip M Pierorazio, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Urologic Oncology|February 23, 2016
Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomyMeera R Chappidi, Max Kates, Hiten D Patel, et al.
Plos One|December 17, 2020
Development and validation of a NanoString BASE47 bladder cancer gene classifierJordan Kardos, Tracy L Rose, Ujjawal Manocha, et al.
The Journal of Urology|January 9, 2018
Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial CarcinomaRoss S Liao, Mohit Gupta, Zeyad R Schwen, et al.
European Urology|November 5, 2021
A Molecular Inquiry into the Role of Antibody-Drug Conjugates in Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder CancerWoonyoung Choi, Kara Lombardo, Sunil Patel, et al.
NMR in Biomedicine|December 21, 2022
Exploring the potential of the novel imidazole-4,5-dicarboxyamide chemical exchange saturation transfer scaffold for pH and perfusion imagingShaowei Bo, Julia Stabinska, Yunkou Wu, et al.
The Journal of Urology|February 9, 2026
Results from the ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) Randomized Controlled TrialMichael E Rezaee, Michelle I Higgins, Zhuo Tony Su, et al.
The Journal of Urology|July 5, 2014
Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failureJames M McKiernan, Dara D Holder, Rashed A Ghandour, et al.
Urologic Oncology|July 13, 2015
Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification toolsDanny Lascano, Jamie S Pak, Max Kates, et al.
European Urology|July 20, 2016
Ex Vivo Model of Human Penile Transplantation and Rejection: Implications for Erectile Tissue PhysiologyNikolai A Sopko, Hotaka Matsui, Denver M Lough, et al.
Urology|November 20, 2013
Survival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical managementHiten D Patel, Max Kates, Phillip M Pierorazio, et al.
Pageof 16